Literature DB >> 34221806

Rapamycin inhibits LOC102553434-mediated pyroptosis to improve lung injury induced by limb ischemia-reperfusion.

Dan Huang1, Lie-Liang Zhang1, Bin Zhou1, Zhen-Zhong Luo1, Jing Zhang1, Bin Tang2, Shu-Chun Yu1.   

Abstract

Limb ischemia reperfusion (I/R) triggers local or systemic injury, and whether the process is mediated by pyroptosis remains unclear, we aimed to explore whether pyroptosis was involved in the process of rapamycin alleviating lung injury induced by I/R and investigate the molecular mechanisms. The histopathology of lung injury induced by I/R was confirmed by hematoxylin-eosin (HE) staining, and malondialdehyde (MDA), superoxide dismutase (SOD), and the expression of pyroptosis related molecules were detected. RNA sequencing was used to mine key long non-coding RNAs (lncRNAs). The model of lipopolysaccharide (LPS)-induced L2 cell damage was also used to explore the effect and mechanism of rapamycin on lncRNA. Rapamycin treatment alleviated I/R-induced lung histopathologically injury and increased the concentration of MDA while decreased activity of SOD and expression of NLRP3, Caspase-1, interleukin-1β (IL-1β), and IL-18 in rat. A total of 63 differentially expressed lncRNAs (DElncRNAs) were identified from IR + Rap group compared with IR group, and these DElncRNAs were mainly involved in cell adhesion molecules (CAMs) and endocytosis pathway. The lncRNA LOC102553434 and its target gene MMP9 were most significantly up-regulated in I/R-injured rat. In vitro experiments showed that LPS induction caused a significant increase in LOC102553434, MMP9, IL-1β, and IL-18 in L2 cells, but rapamycin treatment significantly reversed the effects. After interfering with the expression of LOC102553434 in the LPS-injured cells pretreated with rapamycin, cell proliferation significantly increased, and the expression of MMP, NLRP3 and caspase-1 were significantly decreased. Rapamycin protects the lung from limb I/R injury by regulating LOC102553434 expression and inhibiting pyroptosis pathway. LOC102553434 plays a role in promoting pyroptosis and thus provides a target for clinical treatment of I/R-induced lung injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-021-02708-9. © King Abdulaziz City for Science and Technology 2021.

Entities:  

Keywords:  LOC102553434; Limb ischemia reperfusion; Pyroptosis; Rapamycin

Year:  2021        PMID: 34221806      PMCID: PMC8208454          DOI: 10.1007/s13205-021-02708-9

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  31 in total

1.  Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.

Authors:  Yu-Chang Wang; Qin-Xin Liu; Qiang Zheng; Tao Liu; Xi-E Xu; Xing-Hua Liu; Wei Gao; Xiang-Jun Bai; Zhan-Fei Li
Journal:  Inflammation       Date:  2019-08       Impact factor: 4.092

2.  Tetrahydropalmatine protects against acute lung injury induced by limb ischemia/reperfusion through restoring PI3K/AKT/mTOR-mediated autophagy in rats.

Authors:  Heng Wen; Hu Zhang; Weina Wang; Yuebing Li
Journal:  Pulm Pharmacol Ther       Date:  2020-09-17       Impact factor: 3.410

3.  Imatinib prevents elastase-induced abdominal aortic aneurysm progression by regulating macrophage-derived MMP9.

Authors:  Fengqi Yao; Zhangting Yao; Tiecheng Zhong; Jieqiong Zhang; Tingting Wang; Bo Zhang; Qiaojun He; Ling Ding; Bo Yang
Journal:  Eur J Pharmacol       Date:  2019-07-18       Impact factor: 4.432

4.  Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction.

Authors:  Magdi M I Yassin; Denis W Harkin; Aires A B Barros D'Sa; M Isla Halliday; Brian J Rowlands
Journal:  World J Surg       Date:  2001-10-25       Impact factor: 3.352

Review 5.  Ischaemia-reperfusion injury and hyperbaric oxygen pathways: a review of cellular mechanisms.

Authors:  Ashish Francis; Richard Baynosa
Journal:  Diving Hyperb Med       Date:  2017-06       Impact factor: 0.887

6.  Plasma-derived exosomes contribute to pancreatitis-associated lung injury by triggering NLRP3-dependent pyroptosis in alveolar macrophages.

Authors:  Xiao-Bo Wu; Hong-Yu Sun; Zhu-Lin Luo; Long Cheng; Xing-Mei Duan; Jian-Dong Ren
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-15       Impact factor: 5.187

Review 7.  The functional role of long non-coding RNA in human carcinomas.

Authors:  Ewan A Gibb; Carolyn J Brown; Wan L Lam
Journal:  Mol Cancer       Date:  2011-04-13       Impact factor: 27.401

8.  Long Noncoding RNA AK12348 is Involved in the Regulation of Myocardial Ischaemia-Reperfusion Injury by Targeting PARP and Caspase-3.

Authors:  Chengfei Zheng; Ziheng Wu; Lu Tian; Donglin Li; Xiaohui Wang; Yunjun He; Yangyan He; Wei Jin; Ming Li; Qianqian Zhu; Tao Shang; Hongkun Zhang
Journal:  Heart Lung Circ       Date:  2017-05-26       Impact factor: 2.975

9.  Preconditioning with rHMGB1 ameliorates lung ischemia-reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway.

Authors:  Lin Fei; Xiao Jingyuan; Liang Fangte; Dai Huijun; Ye Liu; Jing Ren; Lin Jinyuan; Pan Linghui
Journal:  J Transl Med       Date:  2020-08-05       Impact factor: 5.531

View more
  2 in total

1.  MMP2 and MMP9 contribute to lung ischemia-reperfusion injury via promoting pyroptosis in mice.

Authors:  Peng Zhou; Nai-Cheng Song; Zhi-Kun Zheng; Yi-Qing Li; Jin-Song Li
Journal:  BMC Pulm Med       Date:  2022-06-15       Impact factor: 3.320

2.  A Novel Risk Model Identified Based on Pyroptosis-Related lncRNA Predicts Overall Survival and Associates With the Immune Landscape of GC Patients.

Authors:  Tingting Xu; Hanxin Gu; Changsong Zhang; Wushuang Zhang; Xiaolong Liang; Xiaoxia Cheng
Journal:  Front Genet       Date:  2022-02-07       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.